Helicobacter pylori and gastric cancer

Gastric Cancer

Volumn 12, Issue 2, 2009, Pages 79-87

  Suzuki, Hidekazu ^a   Iwasaki, Eisuke ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Eradication; Food factor; Gastric cancer; Gene polymorphism; Helicobacter pylori; Randomized controlled trial

Indexed keywords

ALPHA TOCOPHEROL; AMOXICILLIN; ASCORBIC ACID; CLARITHROMYCIN; CYTOCHROME P450 2E1; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 2; GARENOXACIN; GARLIC EXTRACT; GARLIC OIL; GATIFLOXACIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 4; MATRILYSIN; NEUTROPHIL COLLAGENASE; OMEPRAZOLE; PEPSINOGEN; PLACEBO; RIFAMPICIN; ROFECOXIB; SELENIUM; SITAFLOXACIN; TEPRENONE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBIOTIC PROPHYLAXIS; ATROPHIC GASTRITIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DNA POLYMORPHISM; DYSPLASIA; ENZYME BLOOD LEVEL; GARLIC; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; LIFESTYLE; LONG TERM CARE; PEPTIC ULCER; PRECANCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH POLYP; VITAMIN INTAKE;

CLINICAL TRIALS AS TOPIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

EID: 68149166570     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-009-0507-x     Document Type: Review

References (62)

1. H. Suzuki T. Hibi B.J. Marshall 2007 Helicobacter pylori: present status and future prospects in Japan J Gastroenterol 42 1 15 (Pubitemid 46357245)
2. J.R. Warren B.J. Marshall 1983 Unidentified curved bacilli on gastric epithelium in active chronic gastritis Lancet I 1273 1275
3. H. Suzuki T. Nishizawa T. Masaoka M. Mori E. Iwasaki K. Tsuchimoto 2005 Helicobacter pylori infection and gastric cancer JMAJ 48 497 504 (Pubitemid 43019808)
4. IARC. Working Group on the Evaluation of Carcinogenic Risks to Humans. Helicobacter pylori. In: Schistosomes, liver flukes and Helicobacter pylori views and expert opinions of an IARC Working Group On The Evaluation of Carcinogenic Risks To Humans. Lyon: IARC 1994. p. 177-240.
5. D. Forman D.G. Newell F. Fullerton J.W. Yarnell A.R. Stacey N. Wald 1991 Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation BMJ 302 1302 1305
6. A. Nomura G.N. Stemmermann P.H. Chyou I. Kato G.I. Perez-Perez M.J. Blaser 1991 Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii N Engl J Med 325 1132 1136
7. J. Parsonnet G.D. Friedman D.P. Vandersteen Y. Chang J.H. Vogelman N. Orentreich 1991 Helicobacter pylori infection and the risk of gastric carcinoma N Engl J Med 325 1127 1131
8. N. Uemura S. Okamoto S. Yamamoto S. Yamaguchi H. Mashiba K. Taniyama 2001 Helicobacter pylori infection and the development of gastric cancer N Engl J Med 345 784 789 (Pubitemid 34940841)
9. H. Yamagata Y. Kiyohara K. Aoyagi I. Kato H. Iwamoto K. Nakayama 2000 Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study Arch Intern Med 160 1962 1968 (Pubitemid 30437580)
10. B.C. Wong S.K. Lam W.M. Wong J.S. Chen T.T. Zheng R.E. Feng 2004 Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial JAMA 291 187 194 (Pubitemid 38082812)
11. S. Take M. Mizuno K. Ishiki Y. Nagahara T. Yoshida K. Yokota 2005 The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease Am J Gastroenterol 100 1037 1042 (Pubitemid 40769039)
12. J.Q. Huang G.F. Zheng K. Sumanac E.J. Irvine R.H. Hunt 2003 Metaanalysis of the relationship between cagA seropositivity and gastric cancer Gastroenterology 125 1636 1644 (Pubitemid 37500427)
13. N. Uemura T. Mukai S. Okamoto S. Yamaguchi H. Mashiba K. Taniyama 1997 Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer Cancer Epidemiol Biomarkers Prev 6 639 642 (Pubitemid 27342688)
14. W.C. You L.M. Brown L. Zhang J.Y. Li M.L. Jin Y.S. Chang 2006 Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions J Natl Cancer Inst 98 974 983 (Pubitemid 44288162)
15. K. Fukase M. Kato S. Kikuchi K. Inoue N. Uemura S. Okamoto 2008 Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 372 392 397
16. N. Kim R.Y. Park S.I. Cho S.H. Lim K.H. Lee W. Lee 2008 Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up J Clin Gastroenterol 42 448 454 (Pubitemid 351572254)
17. F. Ji Z.W. Wang J.W. Ning Q.Y. Wang J.Y. Chen Y.M. Li 2006 Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial World J Gastroenterol 12 1770 1773
18. C. Wang Y. Yuan R.H. Hunt 2007 The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis Am J Gastroenterol 102 1789 1798 (Pubitemid 47206700)
19. S. Take M. Mizuno K. Ishiki Y. Nagahara T. Yoshida K. Yokota 2007 Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases J Gastroenterol 42 Suppl17 21 27 (Pubitemid 46140359)
20. R. Takenaka H. Okada J. Kato C. Makidono S. Hori Y. Kawahara 2007 Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type Aliment Pharmacol Ther 25 805 812 (Pubitemid 46434921)
21. K. Ogura Y. Hirata A. Yanai W. Shibata T. Ohmae Y. Mitsuno 2008 The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer J Clin Gastroenterol 42 279 283 (Pubitemid 351301494)
22. J. Gwack A. Shin C.S. Kim K.P. Ko Y. Kim J.K. Jun 2006 CagAproducing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea Br J Cancer 95 639 641 (Pubitemid 44325905)
23. S. Hansen S.E. Vollset M.H. Derakhshan V. Fyfe K.K. Melby S. Aase 2007 Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status Gut 56 918 925 (Pubitemid 46999074)
24. D. Palli G. Masala G. Del Giudice M. Plebani D. Basso D. Berti 2007 CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study Int J Cancer 120 859 867 (Pubitemid 46175407)
25. M. Plummer L.J. van Doorn S. Franceschi B. Kleter F. Canzian J. Vivas 2007 Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions J Natl Cancer Inst 99 1328 1334 (Pubitemid 47394171)
26. G. Masuda A. Tokunaga T. Shirakawa A. Togashi T. Kiyama S. Kato 2007 Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years Gastric Cancer 10 98 103 (Pubitemid 46955935)
27. S. Sasazuki M. Inoue M. Iwasaki T. Otani S. Yamamoto S. Ikeda 2006 Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study Cancer Epidemiol Biomarkers Prev 15 1341 1347 (Pubitemid 44125292)
28. M. Sawaya T. Yoshimura T. Shimoyama A. Munakata S. Fukuda 2008 Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori J Clin Gastroenterol 42 351 355
29. M. Tatemichi S. Sasazuki M. Inoue S. Tsugane 2008 Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen Acta Oncol 47 360 365
30. Y. Watanabe N. Aoyama T. Sakai D. Shirasaka S. Maekawa K. Kuroda 2006 HLA-DQB1 locus and gastric cancer in Helicobacter pylori infection J Gastroenterol Hepatol 21 420 424
31. M.S. Al-Moundhri M. Al-Nabhani B. Al-Bahrani I.A. Burney A. Al-Madhani S.S. Ganguly 2006 Interleukin-1 beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population Gastric Cancer 9 284 290 (Pubitemid 44846551)
32. M.A. Garcia-Gonzalez M. Strunk E. Piazuelo R. Benito S. Santolaria P. Jimenez 2006 TGFB1 gene polymorphisms: their relevance in the susceptibility to Helicobacter pylori-related diseases Genes Immun 7 640 646 (Pubitemid 46242368)
33. L. Hou E.M. El-Omar J. Chen P. Grillo C.S. Rabkin A. Baccarelli 2007 Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer Carcinogenesis 28 118 123 (Pubitemid 44942634)
34. F.J. Kubben C.F. Sier M.J. Meijer M. van den Berg J.J. van der Reijden G. Griffioen 2006 Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer Br J Cancer 95 744 751 (Pubitemid 44373491)
35. K.N. Prasad A. Saxena U.C. Ghoshal M.R. Bhagat N. Krishnani 2008 Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease Ann Oncol 19 1299 1303 (Pubitemid 351911961)
36. H. Seno K. Satoh S. Tsuji T. Shiratsuchi Y. Harada N. Hamajima 2007 Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes J Gastroenterol Hepatol 22 729 737 (Pubitemid 46608392)
37. K. Shirai N. Ohmiya A. Taguchi N. Mabuchi H. Yatsuya A. Itoh 2006 Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability J Gastroenterol Hepatol 21 1129 1135 (Pubitemid 43910003)
38. C.A. Gonzalez G. Pera A. Agudo H.B. Bueno-de-Mesquita M. Ceroti H. Boeing 2006 Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPICEURGAST) Int J Cancer 118 2559 2566
39. C.A. Gonzalez P. Jakszyn G. Pera A. Agudo S. Bingham D. Palli 2006 Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC) J Natl Cancer Inst 98 345 354 (Pubitemid 43338214)
40. W.K. Leung E.K. Ng F.K. Chan W.Y. Chan K.F. Chan A.C. Auyeung 2006 Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial Clin Cancer Res 12 4766 4772 (Pubitemid 44297831)
41. C.G. Kim H.J. Song M.C. Kook E.K. Hong S. Park J.Y. Lee 2008 Preoperative versus post operative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial Am J Gastroenterol 103 48 54
42. C.J. Tsai R. Herrera-Goepfert R.J. Tibshirani S. Yang A. Mohar J. Guarner 2006 Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy Cancer Epidemiol Biomarkers Prev 15 272 280 (Pubitemid 43342174)
43. E.M. El-Omar M. Carrington W.H. Chow K.E. [tmp] McColl J.H. Bream H.A. Young 2000 Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 398 402 (Pubitemid 30164342)
44. J. Zabaleta M.C. Camargo M.B. Piazuelo E. Fontham B.G. Schneider L.A. Sicinschi 2006 Association of interleukin-1beta gene poly morphisms with precancerous gastric lesions in African Americans and Caucasians Am J Gastroenterol 101 163 171 (Pubitemid 43381725)
45. M. Steenport H. Eom M. Uezu J. Schneller R. Gupta Y. Mustafa 2007 Association of polymorphisms in myeloperoxidase and catalase genes with precancerous changes in the gastric mucosa of patients at inner-city hospitals in New York Oncol Rep 18 235 240
46. A. Izzotti S. De Flora C. Cartiglia B.M. Are M. Longobardi A. Camoirano 2007 Interplay between Helicobacter pylori and host gene polymorphisms in inducing oxidative DNA damage in the gastric mucosa Carcinogenesis 28 892 908
47. B. Humar F. Graziano S. Cascinu V. Catalano A.M. Ruzzo M. Magnani 2002 Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer Oncogene 21 8192 8195 (Pubitemid 35454423)
48. H. Medina-Franco A. Ramos-De la Medina G. Vizcaino J.L. Medina-Franco 2007 Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population Ann Surg Oncol 14 2246 2249 (Pubitemid 47174898)
49. M. Jenab J.D. [tmp] McKay P. Ferrari C. Biessy S. Laing G.M. Munar 2008 CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) Eur J Cancer 44 774 780
50. M.A. Garcia-Gonzalez A. Lanas E. Quintero D. Nicolas A. Parra-Blanco M. Strunk 2007 Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain Am J Gastroenterol 102 1878 1892 (Pubitemid 47301539)
51. M. Asaka K. Satoh K. Sugano T. Sugiyama S. Takahashi Y. Fukuda 2001 Guidelines in the management of Helicobacter pylori infection in Japan Helicobacter 6 177 186 (Pubitemid 32843601)
52. T. Lind S. Veldhuyzen van Zanten P. Unge R. Spiller E. Bayerdorffer C. O'Morain 1996 Eradication of Helicobacter pylori using 1-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study Helicobacter 1 138 144 (Pubitemid 126671139)
53. T. Nishizawa H. Suzuki K. Kurabayashi T. Masaoka H. Muraoka M. Mori 2006 Gatifloxacin resistance and mutations in gyrA after unsuccessful Helicobacter pylori eradication in Japan Antimicrob Agents Chemother 50 1538 1540
54. H. Miyaji T. Azuma S. Ito H. Suto Y. Ito Y. Yamazaki 1997 Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan Aliment Pharmacol Ther 11 1131 1136 (Pubitemid 27525107)
55. T. Nishizawa H. Suzuki T. Masaoka E. Iwasaki T. Hibi 2007 A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori Digestion 76 215 220 (Pubitemid 351351676)
56. T. Masaoka H. Suzuki K. Kurabayashi Y. Nomoto T. Nishizawa M. Mori 2006 Could frameshift mutations in the frxA and rdxA genes of Helicobacter pylori be a marker for metronidazole resistance? Aliment Pharmacol Ther 24 Suppl.4 81 87
57. T. Matsuhisa T. Kawai T. Masaoka H. Suzuki M. Ito Y. Kawamura 2006 Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori infection in the Japanese population: a multicenter study in the Tokyo metropolitan area Helicobacter 11 152 158 (Pubitemid 43736549)
58. T. Rokkas P. Sechopoulos I. Robotis G. Margantinis D. Pistiolas 2009 Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III Consensus and a third-line empirical regimen Am J Gastroenterol 104 21 25
59. T. Nishizawa H. Suzuki T. Hibi 2009 Quinolone-based third-line therapy for Helicobacter pylori eradication J Clin Biochem Nutri 44 119 124
60. H. Suzuki T. Nishizawa H. Muraoka T. Hibi 2009 Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation Antimicrob Agents Chemother 53 1720 1721
61. P. Gonzalez Carro F. Perez Roldan A. De Pedro Esteban M.L. Legaz Huidobro S. Soto Fernandez O. Roncero Garcia Escribano 2007 Efficacy of rifabutin-based triple therapy in Helicobacter pylori infected patients after two standard treatments J Gastroenterol Hepatol 22 60 63 (Pubitemid 44953417)
62. S. Suzuki H. Suzuki T. Nishizawa F. Kaneko S. Ootani H. Muraoka 2009 Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori Digestion 79 1 4